A screenshot of Hims & Hers’ Super Bowl commercial (Sherwood News)

Hims & Hers threw a Super Bowl Hail Mary that landed incomplete. Now the receiver is on the sidelines.

Hims & Hers did get increased attention from the ad, but the product it showcased for millions of people is no longer at the center of its business model.

J. Edward Moreno

3/12/25 2:12PM

Hims & Hers’ Super Bowl ad attracted controversy, but it also led to a spike in web searches and drove a bump in traffic to the tele-pharmacy’s site.

The commercial focused on weight-loss drugs, though less than two weeks after it was shown to millions of people, the Food and Drug Administration took semaglutide off its shortage list, meaning Hims & Hers can no longer sell copies of Ozempic or Wegovy. The company now has to rethink its strategy on weight-loss drugs.

The ad also ruffled Big Pharma’s feathers, with Novo Nordisk (which makes Ozempic and Wegovy) buying full-page ads in The New York Times and USA Today the Monday after the Super Bowl, questioning the safety of compounded drugs. As Hims & Hers figures out how to move forward, one wrong move could potentially trigger a lawsuit from the Danish pharmaceutical giant.

A Super Bowl ad reportedly cost $8 million per 30-second slot, and Hims & Hers’ ad was one minute long, suggesting it likely cost them about $16 million before production and agency costs.

The company did not immediately respond to a request to comment, including an inquiry about much the ad cost it. Hims & Hers typically spends about half its revenue on marketing, with nearly $679 million spent on marketing last year.

Google searches of “Hims & Hers” spiked on the day of the Super Bowl, according to Google Trends data. But that didn’t necessarily translate to sustained traffic to the company’s website.

Data from Similarweb shows that web traffic to hims.com and forhers.com spiked the day of the Super Bowl, but on a month-over-month basis was less in February than in January, which is typical. (The domain forhims.com also redirects to hims.com, though its traffic is much lower.)

Nate Becker

10h

Paramount is doing everything except the one thing that could give its Warner Bros. bid a chance of success

Warner Bros. says “more than 93%” of its shareholders have rejected Paramount. That’s probably not going to change substantially unless Paramount boosts its offer.

Streamers continued retreating from original shows in 2025

The death of “peak TV” has not been exaggerated, per a new report from Luminate.

Max Knoblauch1/21/26

Retail display of Takis snack food in various spicy flavors in Target store, Queens, New York

America’s love for spicy food and mouth-tingling sauces has surged, but are we approaching “peak heat”?

Takis doesn’t think so, as it searches for a “Chief Intensity Officer.”

Claire Yubin Oh1/21/26

Tom Jones

reduced to tiers

1/21/26

Netflix made $1.5 billion from advertising last year, about 3% of its total revenue

The figure rose more than 2.5x last year, per the company.

Tom Jones1/20/26

OpenAI’s ARR reached over $20 billion in 2025, CFO says

Sam Altman’s $500 billion artificial intelligence behemoth hit a major financial milestone last year, according to a new blog post over the weekend from OpenAI CFO Sarah Friar, as the company confirmed it had hit a more than $20 billion annual revenue run rate at the end of 2025.

Elsewhere in the blog post, Friar spent time addressing the company’s shifting goals, referencing plans to “close the distance between where intelligence is advancing and how individuals, companies, and countries actually adopt and use it.” As has become customary in the AI company press release genre, the CFO was also keen to tout the unending growth of the business, writing:

“Both our Weekly Active User (WAU) and Daily Active User (DAU) figures continue to produce all-time highs. This growth is driven by a flywheel across compute, frontier research, products, and monetization.”
“Compute grew 3X year over year or 9.5X from 2023 to 2025: 0.2 GW in 2023, 0.6 GW in 2024, and ~1.9 GW in 2025.”

And, perhaps most importantly for current backers and those keeping an eye on the private company before its rumored mega IPO:

“Revenue followed the same curve growing 3X year over year, or 10X from 2023 to 2025: $2B ARR in 2023, $6B in 2024, and $20B+ in 2025. This is never-before-seen growth at such scale.”

That latest figure has certainly set tongues in the tech world wagging, just as the company announced it would begin rolling out ads to free and ChatGPT Go users. It also puts the chatbot giant a fair way ahead of competitors like Anthropic, the company behind Claude.

OpenAI Anthropic ARR race — Sherwood News

A business that scales with the value of intelligence

“Both our Weekly Active User (WAU) and Daily Active User (DAU) figures continue to produce all-time highs. This growth is driven by a flywheel across compute, frontier research, products, and monetization.”
“Compute grew 3X year over year or 9.5X from 2023 to 2025: 0.2 GW in 2023, 0.6 GW in 2024, and ~1.9 GW in 2025.”